Long-term botulinum toxin treatment of cervical dystonia - EMG changes in injected and noninjected muscles

Clinical Neurophysiology

Volumn 110, Issue 9, 1999, Pages 1650-1654

  Erdal, J ^a   Ostergaard L ^a   Fuglsang Frederiksen, A ^a   Werdelin, L ^a   Dalager, T ^a   Sjo O ^a   Regeur, L ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Botulinum toxin A; Cervical dystonia; Quantitative electromyography; Sternocleidomastoid muscle

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSTONIA; ELECTROMYOGRAPHY; FOLLOW UP; HUMAN; INJECTION; INTRAMUSCULAR DRUG ADMINISTRATION; LONG TERM CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STERNOCLEIDOMASTOID MUSCLE;

ADOLESCENT; ADULT; AGED; BOTULINUM TOXIN TYPE A; CHILD; DYSTONIA; ELECTROMYOGRAPHY; HUMANS; MIDDLE AGED; NECK MUSCLES; RETROSPECTIVE STUDIES;

EID: 0032819850     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-2457(99)00127-3     Document Type: Article

References (36)

1. Anderson T.J., Rivest J., Stell R., Steiger M.J., Cohen H., Thompson P.D., Marsden C.D. Botulinum toxin treatment of spasmodic torticollis. J Royal Soc Med. 85:1992;524-529.
2. Ansved T., Odergren T., Borg K. Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia. Neurology. 48:1997;1440-1442.
3. Black J.D., Dolly J.O. Selective location of acceptors for botulinum neurotoxin A in the central and peripheral nervous systems. Neuroscience. 23:1987;767-779.
4. Borodic G.E., Joseph M., Fay L., Cozzolino B., Ferrante R.J. Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread. Head Neck. 12:1990;392-399.
5. Buchman A.S., Comella C.L., Stebbins G.T., Tanner C.M., Goetz C.G. Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia. Clin Neuropharmacol. 16:(3):1993;205-210.
6. Christensen H., Lo Monaco M., Dahl K., Fuglsang-Frederiksen A. Processing of electrical activity in human muscle during a gradual increase in force. Electroencephalogr clin Neurophysiol. 58:1984;230-239.
7. Claus D., Druschky A., Erbguth F. Botulinum toxin: influence on respiratory heart rate variation. Mov Disord. 5:1995;574-579.
8. Davidson B.J., Ludlow C.L. Long-term effects of botulinum toxin injections in spasmodic dysphonia. Ann Otol Rhinol Laryngol. 105:1996;33-42.
9. Dubinsky R.M., Gray C.S., Vetere-Overfield B., Koller W.C. Electromyographic guidance of botulinum toxin treatment in cervical dystonia. Clin Neuropharmacol. 14:1991;262-267.
10. Dutton J.J. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects. Surv Ophthalmol. 41:1996;51-65.
11. Finister J., Fuchs I., Mamoli B. Quantitative electromyography-guided botulinum toxin treatment of cervical dystonia. Clin Neuropharmacol. 20:(1):1997;42-48.
12. Fuglsang-Frederiksen A., Sjö O., Winkel H. Quantitative electromyography as a guidance for botulinum toxin treatment of torticollis patients. Muscle Nerve. 14:1991;895.
13. Fuglsang-Frederiksen A. Turns-amplitude analysis of the EMG interference pattern. Methods Clin Neurophysiol. 4:(4):1993;81-100.
14. Fuglsang-Fredriksen A., Østergaard L., Sjö O., Werdelin L., Winkel H. Quantitative electromyographical changes in cervical dystonia after treatment with botulinum toxin. Electromyogr clin Neurophysiol. 38:(2):1998;75-79.
15. Garner C.G., Straube A., Witt T.N., Gasser T., Oertel W.H. Time course of distant effects of local injections of botulinum toxin. Mov Disord. 8:(1):1993;33-37.
16. Gelb D.J., Lowenstein D.H., Aminoff M.J. Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis. Neurology. 39:1989;80-84.
17. Gelb D.J., Yoshimura D.M., Olney R.K., Lowenstein D.H., Aminoff M.J. Change in pattern of muscle activity following botulinum toxin injections for torticollis. Ann Neurol. 29:1991;370-376.
18. Girlanda P., Vita G., Nicolosi C., Milone M., Messina C. Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. J Neurol Neurosurg Psychiatry. 55:1992;844-845.
19. Girlanda P., Quartone A., Sinicropi S., Nicolosi C., Messina C. Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study. Mov Disord. 11:(1):1996;27-33.
20. Jankovic J., Schwartz K.S. Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology. 43:1993;834-836.
21. Lange D.J., Brin M.F., Warner C.L., Fahn S., Lovelace R.E. Distant effects of locally injected botulinum toxin. Muscle Nerve. 10:1987;552-555.
22. Lange D.J., Brin M.F., Fahn S., Lovelace R.E. Distant effects of locally injected botulinum toxin: incidence and course. vol 50. In Fahn, S. editors. Advances in neurology. New York: Raven Press, 1988;609-613.
23. Lange D.J., Rubin M., Greene P.E., Kang U.J., Moskowitz C.B., Brin M.F., Lovelace R.E., Fahn S. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle Nerve. 14:1991;672-675.
24. Lees A.J., Turjanski N., Rivest J., Whurr R., Lorch M., Brookes G. Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin. J Neurol. 239:1992;1-4.
25. Meyer M. Long-term follow-up of cervical dystonia patients treated with botulinum toxin. Eur J Neurol. 2:1995;23-28.
26. Moore A.P., Blumhardt L.D. A double blind trial of botulinum toxin 'A' in torticollis, with one year follow up. J Neurol Neurosurg Psychiatry. 54:1991;813-816.
27. Odergren T., Tollbäck A., Borg J. Electromyographic single motor unit potentials after repeated botulinum toxin treatments in cervical dystonia. Electroenceph clin Neurophysiol. 93:1994;325-329.
28. Olney R.K., Aminoff M.J., Gelb D.J., Lowenstein D.H. Neuromuscular effects distant from the site of botulinum neurotoxin injection. Neurology. 38:1988;1780-1783.
29. Østergaard L., Fuglsang-Frederiksen A., Werdelin L., Sjö O., Winkel H. Quantitative EMG in botulinum toxin treatment of cervical dystonia: a double-blind, placebo-controlled study. Electroencephalogr clin Neurophysiol. 93:1994;434-439.
30. Østergaard L., Erdal J., Fuglsang-Frederiksen A., Werdelin L., Dalager T. Six-year follow-up study of quantitative EMG changes in cervical dystonia treated with botulinum toxin. Acta Neurol Scand. 94:1996;425.
31. Poewe W., Schelosky L., Kleedorfer B., Heinen F., Wagner M., Deuschl G. Treatment of spasmodic torticollis with local injections of botulinum toxin. J Neurol. 239:1992;21-25.
32. Sanders D.B., Massey E.W., Buckley E.C. Botulinum toxin for blepharospasm: single fiber EMG studies. Neurology. 36:1986;545-547.
33. Shaari C.M., George E., Wu B.L., Biller H.F., Sanders I. Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope. 101:1991;960-964.
34. Stell R., Thompson P.D., Marsden C.D. Botulinum toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatry. 51:1988;920-923.
35. 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn-Schmiedeberg's Arch Pharmacol. 292:1976;161-165.
36. Williams R.S., Tse C.K., Dolly J.O., Hambleton P., Melling J. Radioiodination of botulinum neurotoxin type A with retention of biological activity and its binding to brain synaptosomes. Eur J Biochem. 131:1983;437-445.